Related references
Note: Only part of the references are listed.Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus
William J. Steinbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase
Jennifer Nielsen Kahn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans
Carol A. Munro et al.
MOLECULAR MICROBIOLOGY (2007)
Development of candidemia on caspofungin therapy: a case report
Cheung Y. Guo et al.
INFECTION (2006)
Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin
Torsten Neuhof et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Escape of Candida from caspofungin inhibition at concentrations above the MIC (Paradoxical effect) accomplished by increased cell wall chitin;: Evidence for β-1,6-glucan synthesis inhibition by caspofungin
David A. Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy
Morgan Hakki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
FsFKS1, the 1,3-β-glucan synthase from the caspofungin-resistant fungus Fusarium solani
Young-sil Ha et al.
EUKARYOTIC CELL (2006)
Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin
CD Miller et al.
PHARMACOTHERAPY (2006)
Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis
M Laverdière et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient
M Krogh-Madsen et al.
CLINICAL INFECTIOUS DISEASES (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Attenuation of the activity of caspofungin at high concentrations against Candida albicans:: Possible role of cell wall integrity and calcineurin pathways
NP Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans
TT Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Cell wall integrity signaling in Saccharomyces cerevisiae
DE Levin
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin
RE Gardiner et al.
MEDICAL MYCOLOGY (2005)
An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae -: art. no. 8
G Lesage et al.
BMC GENETICS (2005)
Multiechinocandin- and multiazole-resistant Candida parapsilosis solates serially obtained during therapy for prosthetic valve endocarditis
V Moudgal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: Case report and review of literature
R Pelletier et al.
MEDICAL MYCOLOGY (2005)
The global transcriptional response to transient cell wall damage in Saccharomyces cerevisiae and its regulation by the cell integrity signaling pathway
R García et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Caspofungin resistance in Candida albicans:: Correlating clinical outcome with laboratory susceptibility testing of three is genic isolates serially obtained from a patient with progressive candida esophagitis
S Hernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Proteomic analysis of Candida albicans cell walls reveals covalently bound carbohydrate-active enzymes and adhesins
PWJ de Groot et al.
EUKARYOTIC CELL (2004)
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis
RM Prabhu et al.
CLINICAL INFECTIOUS DISEASES (2004)
Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae
S Markovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Chitin synthesis in Saccharomyces cerevisiae in response to supplementation of growth medium with glucosamine and cell wall stress
DA Bulik et al.
EUKARYOTIC CELL (2003)
The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function
PR Kraus et al.
MOLECULAR MICROBIOLOGY (2003)
Calcineurin A of Candida albicans:: involvement in antifungal tolerance, cell morphogenesis and virulence
D Sanglard et al.
MOLECULAR MICROBIOLOGY (2003)
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
DP Kontoyiannis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Caspofungin activity against clinical isolates of fluconazole-resistant Candida
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
CHS8 - a fourth chitin synthase gene of Candida albicans contributes to in vitro chitin synthase activity, but is dispensable for growth
CA Munro et al.
FUNGAL GENETICS AND BIOLOGY (2003)
The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling
C Reinoso-Martin et al.
EUKARYOTIC CELL (2003)
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro
JC Bowman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The genetic complexity of chitin synthesis in fungi
C Roncero
CURRENT GENETICS (2002)
Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans
MA Uhl et al.
MICROBIOLOGY-SGM (2001)
Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity
CA Munro et al.
MOLECULAR MICROBIOLOGY (2001)
Identification of a novel inhibitor specific to the fungal chitin synthase -: Inhibition of chitin synthase 1 arrests the cell growth, but inhibition of chitin synthase 1 and 2 is lethal in the pathogenic fungus Candida albicans
M Sudoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of the chitin biosynthesis process as a compensatory mechanism in the fks1 mutant of Saccharomyces cerevisiae
LJ García-Rodriguez et al.
FEBS LETTERS (2000)
Synergistic antifungal activities of bafilomycin A1, fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans
M Del Poeta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
